论文部分内容阅读
澳大利亚使用肺炎球菌活疫苗的经验肺炎球菌活疫苗于2001年2月在澳大利亚注册登记,用于6周-9岁婴儿及儿童自动免疫,以预防肺炎链球菌引起的肺炎及中耳炎。疫苗含7种血清型的肺炎球菌。此7种菌型覆盖85％澳大利亚城市儿童及67％土著儿童。在一临床儿童免疫试验中,肺炎链球菌活疫苗对儿童发生肺炎的预防有效率达97％。
Pneumococcal Live Vaccine Experience in Australia The live pneumococcal vaccine was registered in Australia in February 2001 for autoimmunization of infants and children aged 6 weeks to 9 years to prevent pneumonia and otitis media caused by Streptococcus pneumoniae. The vaccine contains 7 serotypes of pneumococci. These seven bacteria cover 85% of Australian urban children and 67% of Indigenous children. In a clinical childhood immunization trial, live pneumococcal vaccine was effective in preventing pneumonia in children by 97%.